Congratulations to Dr. Jinglin Fu—awarded an NIH grant to develop nucleic-acid nanoparticles that deliver CRISPR/Cas9 to blood stem cells!
Backed by nearly $500,000 in NIH funding, Dr. Fu’s team is designing nucleic-acid nanoparticles to ferry genome-editing tools into hematopoietic (blood) stem cells. If successful, the approach could accelerate next-generation therapies for inherited disorders such as sickle-cell disease. The work takes place in Fu’s Bio-Mimetic Design and Nanoscience Lab at the Joint Health Sciences Center,… continue reading